The treatment of Cataracts & Cholestasis with vitamins

Cataracts and Cholestasis: Mitamins custom make quality formulas for the treatment of Cataracts & Cholestasis with vitamins. A Cataracts & Cholestasis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Cholestasis

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    Vitamin K
    10
    mcg
    13%
    Riboflavin
    75
    mg
    4412%
    Selenium
    200
    mcg
    286%
    Alpha Lipoic Acid
    50
    mg
    *
    Lutein
    6000
    mcg
    *
  • Amount Per Serving
    % DV
    SAMe
    400
    mg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    Milk Thistle Extract
    100
    mg
    *
    L-Glutamine
    100
    mg
    *
    Dandelion Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Cataracts and Cholestasis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Doctors Warn Of Climate Havoc Resulting In Global Disease Epidemics And Famine
Even a limited, regional nuclear war, such as an exchange between India and Pakistan, would cause world wide climate disruption and lead to global famine, according to papers being presented at an international conference at the Royal Society of Medicine this week.
European Committee Issues Positive Opinion On Wyeth's TORISEL For Advanced Renal Cell Carcinoma
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) for the approval of TORISEL? (temsirolimus) as a first-line therapy for patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors.
This information concerning the support of Cataracts and Cholestasis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments